(21, 36, 37) Several studies have suggested that CD4-postiive CAR T cells contribute to CRS development to a greater degree than CD8-positive CAR T cells, indicating that the CD4/CD8 ratio of the CAR product may be potentially be predictive for CRS (34, 38). The gene discussed is CD4; the disease is congenital rubella syndrome.